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Abstract  
 
Background - Evidence shows that exercise is beneficial for people with MS, however 
statistical pooling of data is difficult due to the diversity of outcome measures used. 
 
Objective- To report the recommendations of an International Consensus Meeting for a core 
set of outcome measures for use in exercise studies in MS. 
 
Methods – From the 100 categories of the International Classification of Function core sets 
for MS, 57 categories were considered as likely/potentially likely to be affected by exercise 
and were clustered into seven core groups. Outcome measures to address each group were 
evaluated regarding e.g. psychometric properties. 
 
Results - The following are recommended; Modified Fatigue Impact Scale (MFIS) or Fatigue 
Severity Scale (FSS) for energy and drive, 6 minute walk test (6MWT) for exercise tolerance, 
timed up and go (TUG) for muscle function and moving around, Multiple Sclerosis Impact 
Scale (MSIS-29) or MSQoL54 for quality of life and Body Mass Index (BMI) or Waist-hip ratio 
(WHR) for the health risks associated with excess body fat. A cost effectiveness analysis and 
qualitative evaluation should be included where possible. 
 
Discussion –Using these core measures ensures that future meta-analyses of exercise 
studies in MS are more robust and thus more effectively inform practice. 
Introduction 
While the pharmaceutical industry has made advancements in identifying drug therapies to 
attenuate symptoms and disease progression for people with MS, great strides have also 
been made with respect to non-pharmacologic interventions.  
 Exercise is a safe, non-pharmacological treatment strategy for people with MS that can 
bring many health benefits, including improvements in muscle power, physical and 
psychosocial functioning and quality of life1-3. Regular exercise participation may also have 
an important role to play in the management of fatigue4, which negatively affects quality of 
life5, mental alertness6 and cognitive processing7. Although people with MS have 
traditionally been advised to refrain from exercise because of the increased risk of triggering 
an exacerbation of symptoms due a rise in core temperature1, any increase in symptoms is 
usually transient (generally 30 minutes or less) and there is no evidence of lasting 
detrimental effects on fatigue or function8. 
 
Indeed, due to a rapidly expanding evidence base, exercise has become one of the key 
components of rehabilitation and long term management of people with MS to optimise 
function and maintain health.  In the UK, the National Institute for Health and Care 
Excellence (NICE) recommends aerobic exercise for helping to control the burden of fatigue, 
motor weakness and musculoskeletal pain in people with MS9. This is supported by leading 
charitable trusts (e.g. the UK MS Society and MS Trust), who are actively promoting the 
benefits of exercise for improving mobility, mental health status and cardiovascular risk 
profile to enhance health-related quality of life (HRQoL) and reduce the MS healthcare 
burden. 
 
Despite the growing evidence base, recent systematic and narrative reviews have 
highlighted the need for consensus on a core set of outcome measures for exercise studies. 
A key publication, the 2005 Cochrane Systematic Review1, reported that statistical pooling 
of the data from MS exercise studies was not possible due to the large number of outcome 
measures used and concluded that there was an urgent need for a consensus on a core set 
of outcome measures for exercise studies in MS to improve the robustness of future meta-
analyses and to ensure that they more effectively inform clinical practice. Since then, a 
number of reviews on the effects of exercise for people with MS have been published yet 
the problem of multiple outcome measures and the resultant difficulty of statistical pooling 
remains.  
 
For example, in their review, Asano et al.10 stated that whilst there was evidence that 
exercise offered some benefits for people with MS, especially in terms of function and 
physical activity, advanced statistical analysis was not possible due to the amount and 
heterogeneity of outcome measures used. Dalgas et al.11 reviewed the evidence for 
resistance, endurance and combined exercise and concluded that there were only a few, 
methodologically poor and underpowered studies and thus, no conclusions could be made. 
The review also highlighted the large number of outcome measures included in the studies 
reviewed. Finally, Motl & Gosney2 investigated the effects of exercise on quality of life (QOL) 
in people with MS and concluded that aerobic exercise in excess of 90 minutes per week can 
improve QOL but only if measured with a disease specific QOL scale. Importantly, a total of 
18 different QOL measures were used in 13 studies. 
 
To advance clinical practice and develop guidelines for the application of exercise for people 
with MS sufficient evidence of treatment effectiveness is essential. This involves expensive, 
large scale studies or statistical pooling and meta-analysis of data from small scale studies, 
which is currently hampered due to the heterogeneity of outcome measures used. Although 
the Cochrane Systematic Review in 20051 highlighted the need for a core set of outcomes, 
to date, this has not been proposed. Hence, a meeting of a group of international experts 
from a range of disciplines was held to discuss outcome measures in MS with the purpose 
being to recommend a core set of outcome measures for use within exercise studies in MS. 
This paper reports on the findings of this meeting. 
Methods 
The consensus group consisted of 12 people, most of whom were internationally recognised 
for their MS research. They came from a range of professional backgrounds; physiotherapy, 
exercise science, exercise psychology and health economics as well as a representative from 
the MS Society UK and two expert patients with MS. Participants attended from the UK, 
New Zealand, Ireland and the USA. The MS Society UK sent a representative to the meeting 
and also assisted with recruiting the two individuals with MS through their Research 
Network. Funding was secured from the Multiple Sclerosis International Federation (MSIF) 
and the Consensus Meeting took place at the University of Glasgow on 15th and 16th of 
February 2012.  
 
The EDGE (Evaluation Database to Guide Clinical Effectiveness)Task Force12 of the American 
Physical Therapy Association had produced MS-EDGE outcome measures for acute, in -
patient and out-patient management of people with MS and also for clinicians undertaking 
research. While this work primarily focused on clinical practice and specifically on physical 
therapy, the detailed evaluation by the EDGE group e.g. outlining the validity and reliability 
of relevant outcome measures was an invaluable resource. Therefore, following dialogue 
with the Chair of the MS-EDGE group, these documents were used to support/inform some 
of the discussion of the consensus meeting. 
 
In the preparatory phase discussions took place, by email, in advance of the meeting. The 
group agreed that an overall framework was required to structure further discussion and for 
reporting recommendations for a core set of outcome measures. The group agreed that the 
International Classification of Functioning, Disability and Health (ICF) would be used as the 
framework (WHO 2001), specifically the Core Sets for Multiple Sclerosis which had recently 
been published13. The ICF Core Sets for MS contains 40 body functions, 7 body structures 
and 53 activities and participation categories (100 categories) as well as 38 environmental 
categories in order to comprehensively describe the function and disability of people with 
MS based on the ICF. The ICF Core Sets for MS were used as the framework for determining 
the recommended core set of outcome measures for exercise studies in MS. However, as 
the environmental categories were part of the external factors, they were not included in 
the discussion as they could not be influenced by exercise. 
 
At the meeting the group discussed the meaning and value of core outcomes and agreed 
that the core group of outcome measures should contain as few outcomes as possible but 
as many as necessary to cover the core domains affected by exercise. In addition the group 
identified that, for the core set of outcomes to have utility, they would have to be 
acceptable to various stakeholders: patients and their families, patient groups and charities, 
clinicians and researchers, research funding agencies, health funders/commissioners, ethics 
committees and journal editorial boards. The group listed and agreed factors and criteria 
which would be considered when discussing specific outcome measures (Table 1). 
 
Table 1 Near Here 
 
In Stage 1 of the structured review process, each of the 100 categories from the Core Sets 
for MS was discussed and classified as a) likely b) potentially likely or c) unlikely to be 
affected by exercise. As an example, under body functions ‘exercise tolerance’ was classified 
as likely to be affected by exercise, ‘urinary function’ as potentially affected by exercise and 
‘fluency and rhythm of speech functions’ as unlikely to be affected by exercise. Similarly, 
under Activities and Participation ‘transferring oneself’ was classified as likely to be affected 
by exercise, ‘higher education’ as potentially affected by exercise and ‘religion and 
spirituality’ as unlikely to be affected by exercise. The results of Stage 1 are shown in Table 2 
which provides the list of categories likely, potentially like or unlikely to be affected by 
exercise. Forty categories were considered likely to be affected by exercise, 17 as potentially 
likely to be affected by exercise and 36 as unlikely to be affected by exercise (Table 2). Those 
categories unlikely to be affected by exercise were then excluded from further discussion. 
The seven body structures were considered at the next stage. 
Table 2 Near Here 
 
In Stage 2, the categories deemed to be likely or potentially likely to be affected by exercise 
were then examined and, where relevant, combined into groups. For example 10 categories 
were clearly related to activities of daily living (ADL) e.g. dressing, eating and were therefore 
grouped into a category of ADL, 10 categories related to moving around e.g. moving around 
in different locations, changing body position and four categories were related to muscle 
function e.g. muscle tone, muscle power. 
 
Stage 2 resulted in eight groupings: energy and drive (fatigue), emotional function, exercise 
tolerance, muscle function, moving around, ADL, recreation and leisure and quality of life. 
 
Also at this stage consideration was given to the seven body structures. These were mainly 
anatomical areas e.g. structure of lower limb, brain, trunk and as such likely to be affected 
by exercise but were discussed within the groupings identified. These were grouped under 
body structures, thus making nine groupings.  
 
In Stage 3 each grouping was discussed in terms of whether assessment of that grouping in 
practice would be determined as a core part of the assessment in studies of exercise in MS. 
From this discussion, emotional function and recreation and leisure were not deemed to be 
core and therefore were not included in further discussion. 
  
In Stage 4 the remaining seven groupings were considered in small groups. A list of possible 
outcome measures was drawn up which would address each grouping. The MS-EDGE 
documents were used as a resource for this stage. Each outcome measure was considered 
in relation to the specific criteria previously agreed (Table 1).  
 
In Stage 5 each small group provided a summary of their findings to the whole group. The 
group discussed and debated the utility of each measure and subsequently agreed on the 
outcome measure being recommended for each grouping. 
  
In the final stage, Stage 6 the list of core outcome measures was considered by the group 
and final recommendations agreed.  
 
Results 
The consensus group recommend that the outcome measures shown in Table 3 are used, 
where possible, in studies of exercise in MS. Table  4 shows further detail on the 
recommended outcomes in terms of the criteria in Table 1. 
 
Table 3 Near Here 
Table 4 Near Here 
 
 
The group recommended that, based on the current published literature available, all 
exercise based research studies in people with MS should include measures of energy and 
drive (fatigue), exercise tolerance, muscle function, moving around, ADL, quality of life and 
body structures. For energy and drive (fatigue) the Modified Fatigue Impact Scale (MFIS)16 is 
recommended as it encompasses a multidimensional assessment of fatigue however in 
situations where unidimensional assessment is sufficient the Fatigue Severity Scale (FSS)17 
could be used. For the assessment of exercise tolerance the 6 minute walk test (6MWT)18 is 
recommended. The timed up and go (TUG)19 is recommended to assess both muscle 
function and moving around. For quality of life the Multiple Sclerosis Impact Scale (MSIS-
29)14 or MSQoL5415 are recommended and the simple measures of Body Mass Index (BMI) 
or Waist-hip ratio (WHR) are recommended as measures of the body composition20.  
 
The group considered a measure of Activities of Daily Living (ADL) to be important however 
it was not possible to recommend a suitable measure as none of the available measures met 
the necessary criteria (Table 1). 
 
All the outcome measures recommended are appropriate across a range of disability with 
the exception of TUG and 6MWT which are not appropriate for those who are non-
ambulatory. For those who are non-ambulatory, for  the ‘moving around’ dimension, it was 
not possible to recommend a measure which was robust, valid and did not require a licence 
for use.  
 
Although there was unanimous agreement of the importance of including assessments of 
cost-effectiveness it was not possible to recommend one specific resource use measure due 
to the differing health care systems. Rather, the principle of taking a comprehensive 
approach to measuring service use and broader societal costs should be adopted and locally 
appropriate measures (e.g. patient questionnaires, administrative data) be used for this. In 
some countries it is appropriate to combine cost data with quality-adjusted life years 
(QALYs) using a measure such as the EQ5D39. Where QALYs are not required for healthcare 
decision making this approach may not be required. 
   
The group also recommended that, where appropriate, the results of the quantitative 
measures recommended be supplemented with a qualitative evaluation. The latter is 
important to provide an understanding of the obtained results and to gleen a more 
comprehensive perspective of how exercise programmes may affect people with MS. 
  
Discussion 
Our goal was to identify and select the most appropriate outcome measures for use in 
exercise based research as one step in the process toward the application and evaluation of 
exercise in people with MS. 
 
The outcome measures recommended by the consensus group are a combination of patient 
reported outcome measures (PROMS); MSIS-29, MSQoL53, MFIS, FSS: rater/time based 
tests; TUG, 6MWT, and objective measures; BMI, waist/hip ratio. Schaffler et al (2013)40 
suggest that such a combination is an appropriate triad of outcome measures, and in 
particular they highlight the growing importance of the inclusion of PROMS in the 
assessment of MS. Additionally the core outcomes consider a range of body structures, 
functions, activity limitations and participation restrictions in line with the ICF core sets for 
MS13.  
 
The core outcome measures recommended are commonly used assessments which are 
relatively quick to complete, require no specialised equipment or training and have minimal 
cost implications. It should therefore be feasible to include these outcome measures in most 
studies of exercise in MS. Also of note, with the exception of FSS and the body composition 
measures (BMI and WHR), all the core outcomes recommended are contained with the MS 
EDGE Outcome measures for Research (of which there are 27 recommended measures). The 
omission of the body composition measures (BMI and WHR) from the EDGE measures may 
be a reflection of this consensus group being multi-professional, including exercise science, 
compared to the specific physical therapy focus of the EDGE group. The inclusion of body 
composition measures BMI and WHR, which assess the health risks associated with excess 
body fat, is viewed as a strength of the recommended core group of outcome measures, as 
their inclusion allows the research/practise agenda to move beyond the symptom 
management/disability focus and to consider the role of exercise in the prevention of 
secondary health problems such as cardiovascular disease and diabetes in people with MS. 
 
Importantly, the outcome measures recommended are not intended as the only measures 
for use in exercise studies but that these core measures are included within the battery of 
relevant outcome measures which address the research questions posed by the 
investigators of individual studies. For example a studying designed to investigate the 
effects of resistance muscle training would include outcome measures such as muscle 
strength or power but would also include the recommended core outcome measures.  
 
In our discussion of the two related areas of Activities of Daily Living and ‘moving around’ 
for those who were non-ambulatory, we determined that no measure was available which 
fulfilled our criteria for inclusion as an outcome measure (Table 1). Although there are many 
ADL measures most require specific training in their use e.g. the Functional Independence 
Measure (FIM) or require a licence e.g. the Canadian Occupational Performance Measure 
(COPM). These measures are well validated within the literature however due to 
accessibility issues are not appropriate within a core set of outcome measures. The difficulty 
in recommending a specific measure in this area may be a reflection of the literature base 
being focussed mainly on the effects of exercise in those with relapsing remitting forms of 
the disease with relatively few studies investigating the effects of exercise for those with 
progressive MS. There is an urgent need to develop a robust, easily accessible outcome 
measure to evaluate ADL and ‘moving around’ in people with MS who are non ambulatory. 
 We propose that these outcome measures be reviewed regularly, at least every five years. 
This is important in light of the evolving evidence base, the publication of new outcome 
measures and the continued validation/update of existing outcome measures. For example 
the Neurological Fatigue Index for Multiple Sclerosis (NFI-MS)41 and the Fatigue Scale for 
Motor and Cognitive Functions (FSMC)42 are relatively new measures of fatigue. These were  
considered but at the time of the consensus meeting there was insufficient evidence on 
their psychometric properties or their research utility to consider them for inclusion as a 
core outcome measure41 However, when the core outcomes are reviewed the results of 
recent studies41, 43, 44 may provide stronger evidence to support their inclusion.  
 
Limitations 
The consensus group was relatively small, all English speaking and, although it was multi-
disciplinary it did not include representatives from some relevant professional groups such 
as occupational therapists which would have been valuable. While the group contained 
internationally leading researchers and expert reviewers for the MS Society budgetary 
restrictions limited the number of geographical locations represented. It is possible that a 
different group of researchers might recommend a different set of core measures, however 
it should be noted that consensus was achieved by those present. 
 
All the core outcome measures are widely used and available in English formats. Future 
reviews of the core outcome measures should consider if these outcomes are validated in a 
range of different languages to support the use of the core outcomes in countries where 
English is not the principal language. 
 Conclusion 
The consensus group recommendations are that all exercise studies in MS include the 
following outcome measures; the Modified Fatigue Impact Scale (MSIF) or the Fatigue 
Severity Scale (FSS), the 6 minute walk test (6MWT), the timed up and go (TUG), the 
Multiple Sclerosis Impact Scale (MSIS-29) or MSQoL54 and Body Mass Index (BMI) or Waist-
hip ratio (WHR). These measures should not be to the exclusion of others relevant to the 
research question(s) of specific studies. Where possible, it is recommended that the core 
outcome measures are augmented by qualitative evaluation and an assessment of the 
cost/benefit of the exercise intervention, based on local nationally accepted methods, is 
included. 
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Table 1 – Factors considered when discussing/making recommendations regarding outcome 
measures 
Factors considered 
Psychometric properties of the outcome measure including reliability, validity, 
responsiveness to change 
Self report or performance measure 
Generic or MS specific measure 
The time taken to complete the assessment 
The patient/clinician/ administrator burden involved 
Any resources required including equipment, specialist skills, space 
The appropriateness of the measure across the disability range 
The specificity of the measure in terms of the type of exercise e.g. aerobic, 
resistance 
Whether measures were under licence 
The availability of normative data 
Time frame e.g. questionnaires relating to previous 7 days or 4 weeks 
 
 
 
  
Table 2 –Stage 1 - each of the 93 categories of the ICF Core set deemed likely/potentially 
likely or unlikely to be affected by exercise 
 Likely to be affected 
(n=40) 
Potentially affected 
(n=17) 
Unlikely to be affected 
(n=36) 
Body Function 
(n=40) 
Energy Level 
Energy and drive functions 
Sleep functions 
Emotional function 
Respiratory muscle function 
Exercise tolerance function 
Sensation of pain 
Mobility of joint functions 
Muscle power functions 
Muscle tone functions 
Muscle endurance 
functions 
Involuntary contraction of 
muscles 
Gait pattern functions 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(n= 13) 
Defecation functions 
Urinary functions 
Motor reflex functions 
Control of voluntary 
movement functions 
Tremor 
Sensations related to 
muscles and movement 
functions 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(n= 6) 
Orientation function 
Temperament and 
personality functions 
Motivation 
Attention functions 
Memory functions 
Perceptual functions 
Higher level cognitive 
functions 
Seeing functions 
Vestibular functions 
Proprioceptive functions 
Touch function 
Sensory functions related to 
temperature 
Voice functions 
Articulation functions 
Fluency and rhythm of 
speech functions 
Salivation 
Swallowing 
Body temperature 
Thermoregulatory function 
(heat) 
Thermoregulatory function 
(cold) 
Sexual function 
 
(n=21) 
 
Activities and 
Participation 
(n= 53) 
Carrying out daily routine 
Handling stress and other 
psychological demands 
Changing basic body 
position 
Maintaining a body position 
Transferring oneself 
Lifting and carrying objects 
Hand and arm use 
Walking 
Moving around 
Moving around in different 
locations 
Moving around using 
equipment 
Using transportation 
Driving 
Washing oneself 
Caring for body parts 
Acquiring skills 
Fine hand use 
Assisting others 
Basic interpersonal 
interactions 
Complex personal 
interactions 
Informal social interactions 
Family relationships 
Intimate relationships 
Vocational training 
Higher education 
Acquiring, keeping and 
terminating a job 
 
 
 
 
 
Watching 
Focussing attention 
Thinking 
Reading 
Writing 
Solving problems 
Making decisions 
Undertaking a single task 
Undertaking multiple tasks 
Speaking  
Conversation 
Using communication 
devices 
Basic economic transactions 
Economic self-sufficiency 
Religion and spirituality 
 
 
 
Toileting 
Dressing 
Eating  
Drinking 
Looking after ones health 
Acquisition of goods and 
services 
Preparing meals 
Doing housework 
Caring for household 
objects 
Remunerative employment 
Community life 
Recreation and leisure 
 
(n= 27) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(n=11) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(n=15) 
 
Table 3 Recommended Core Outcome Measures for exercise studies in MS 
 
Dimension Outcome Measure(s) 
Quality of Life Multiple Sclerosis Impact Scale (MSIS-29)14 
or 
MSQoL5415 
Energy and drive (fatigue) Modified Fatigue Impact Scale (MSIF)16 
(multi-dimensional) 
or 
Fatigue Severity Scale (FSS)17  
(uni-dimensional) 
Exercise Tolerance 6 Minute Walk Test (6MWT)18 
 
Muscle function/moving around Timed up and Go (TUG)19 
 
Body Structure 
(body composition) 
Waist-hip ratio (WHR)  
Body Mass Index (BMI)20 
 Table 4 Detail of the Recommended Core Outcome Measures 
 
Factors considered MSIS-29 MSQoL54 MFIS FSS 6MWT TUG BMI WHR 
Psychometric 
properties of the 
outcome measure 
including reliability, 
responsiveness to 
change 
Internal 
Consistency: 
Cronbach’s alpha 
values .96 (physical 
scale), .91 
(psychological 
scale) n=703 14 
Inter-rater 
reliability  
ICC 0.58 for 
physical and  0.34 
for psychological21 
Test-retest 
reliability: 
ICC 0.94 (physical), 
0.87(psychological) 
n=12814 
ICC 0.87(physical), 
0.83 (psychological 
n=3021 
MDC/responsivene
ss   
Change in 8 points 
is clinically 
significant (baseline 
to 4 yrs), n= 21422 
 
Internal Consistency 
Cronbach’s alpha 
values .75-.96 for 12 
subscales 15.  
No inter/intra rater 
reliability data  
Test-retest reliability  
ICC 0.66 to 0.9615 
MDC/responsiveness  
No MDC or MICD 
values. 
More sensitive to 
change than generic 
QOL measures in 
patients receiving 
steroid treatment 23.  
 
 
 
Internal Consistency: 
Cronbach’s alpha 
values > .94 for total 
score, physical and 
cognitive subscores   
n= 1721  pwMS24 
Test-retest reliability:  
ICC = 0.85, physical 
0.73, cognitive 0.88, 
psychosocial 0.81 n= 
43 ambulatory MS25  
ICC =0.86, physical 
0.86, cognitive 0.84, 
psychosocial 0.78 n= 
8226 
MDC/Responsiveness 
MDC: Total score 
19.3%, physical 
24.7%, cognitive 
20%, psychosocial 
28.8% in pwMS27  
Smallest detectable 
difference (points 
change): total 16.2, 
physical 8.9, 
cognitive 8.0, 
psychosocial 2.3 in 
pwMS27   
SEM 7.3 points, CV 
21.4%, MDC: 20.2 
Internal 
Consistency: 
Cronbach’s alpha 
value .93 in 1721 
people with MS24 
Test-retest 
reliability 
ICC 0.76 n= 43 
ambulatory 
pwMS 27 
ICC total score 
0.75 in 82 pwMS 
over 6 month 
retest period26 
MDC/ 
Responsiveness 
MDC 20.7% 27 
SEM 0.7 points, 
CV 10.3%, MDC 
1.9 points in 82 
people with MS 
over 6 month 
retest period26  
 
Intra-rater 
reliability 
ICC = 0.91; n=40, 
EDSS range 0 – 
6.518   
ICC = 0.98, n=12 
EDSS 0-6.528 
Inter-rater 
reliability 
 ICC = 0.94, n= 40, 
EDSS range 0 – 
6.518,  
ICC = 0.93  n=19, 
EDSS ≤6.529. 
ICC=0.96, n=24 
EDSS 5-6.530 
Test-retest 
reliability 
 ICC = 0.96, n=12, 
EDSS 2.0 – 6.531  
ICC = 0.96 , n=19, 
EDSS ≤ 6.529. 
ICC=0.959 n=82 
EDSS 0-6.526 
MDC/ 
Responsiveness 
±92.16m , n=120, 
EDSS 0-6.532 
 
 
Intra-rater 
reliability 
No MS specific 
data 
Test- retest 
reliability 
ICC=0.91 
(0.83-0.95), 
EDSS </= 4: 0.84 
(0.66-0.93), 
EDSS > 4: 0.88 
(0.76-0.95)33 
ICC=0.97, n=24 
EDSS 5-6.530 
MDC/ 
Responsiveness 
MDC 12.6s n=24 
EDSS 5-6.530 
Each 
laboratory 
to 
determine 
its own 
reliability 
data.  
 
Body mass 
index is 
calculated 
by dividing 
body weight 
in kilograms 
(kg) by 
height (m) 
squared 
(kg/m2).20 
Each laboratory 
to determine 
its own 
reliability data.  
 
Hip 
circumference 
is measured at 
the widest 
portion of the 
buttocks and 
waist 
circumference 
is measured at 
the narrowest 
part of the 
torso between 
the iliac crest. 
In obese 
people, waist 
circumference 
is measured on 
a horizontal 
plane around 
the abdomen 
at the level of 
the iliac crest.20 
 points n= 8226  
Self report or 
performance 
measure 
Self Report Self Report Self Report Self Report Performance Performance Objective 
measure 
Objective 
measure 
Generic or MS 
specific measure 
MS Specific MS Specific MS Specific Generic Generic Generic Generic Generic 
The time taken to 
complete  
10-15 minutes 10-20minutes 5-10minutes 5 minutes  6 minutes 1-2minutes 5 minutes 5 minutes 
The 
patient/clinician/ 
administrator 
burden involved 
Minimal Minimal but scoring 
is time consuming.   
(10-20 minutes) 
Minimal Minimal Minimal Minimal Minimal Minimal 
Any resources 
required; 
equipment, 
specialist skills, 
space 
None None None None Stopwatch, Two 
small cones to 
mark turning 
point, A chair that 
can be moved 
anywhere on the 
track, Worksheets 
& clipboard, 
Stopwatch, 
47-cm-high 
chair with arm 
and back 
supports, cone, 
tape,  3m 
walkway 
Scales to 
weigh the 
person and a 
stadiometer 
for height 
measure-
ment (or 
measuring 
tape)  
Measuring tape 
The 
appropriateness of 
the measure across  
disability range 
Applicable across 
the disability range 
Applicable across the 
disability range 
0.0 – 7.512. May not 
be appropriate for 
EDSS score 8 and 
above  
0.0 – 7.512. May 
not be 
appropriate for 
EDSS score 8 and 
above  
Ambulatory 
people only, rests 
are permitted  
All ambulatory 
people with MS 
can complete 
Applicable 
across the 
disability 
range 
Applicable 
across the 
disability range 
The specificity of 
the measure in 
terms of the type of 
exercise e.g. 
aerobic, resistance 
Not specific to type 
of exercise as 
captures 
information on 
quality of life 
Not specific to type 
of exercise as 
captures information 
on quality of life 
Not specific to type 
of exercise as 
measures  the effects 
of fatigue on 
physical, cognitive 
and psychosocial 
Not specific to 
type of exercise 
as measures 
severity of fatigue 
and it affect on 
activities and 
Not specific to 
type of exercise 
as measures 
walking 
endurance 
Not specific to 
type of exercise 
as captures sit 
to stand, 
balance and gait 
functions 
Not specific 
to type of 
exercise as 
captures 
information 
on body 
Not specific to 
type of 
exercise as 
captures 
information on 
body 
 functioning  lifestyle composition composition 
Licence required No No No (under copyright) No No  No No No 
The availability of 
normative data 
Minimal change in 
physical score (0.9) 
in 553 pwMS over 
300 days34 
No No Limited35 Yes36-38 Yes36 Cut-points 
for health20 
Cut-points for 
health20 
Time frame e.g. 
questionnaires 
relating to previous 
7 days or 4 weeks 
2 weeks 4 weeks 4 weeks  Current 
performance 
Current 
performance 
Data relates 
to measures 
taken at that 
time point 
Data relates to 
measures 
taken at that 
time point 
 
 
 
 
 
